参考文献/References:
[1] KEARON C, KAHN S R. Long-term treatment of venous thromboembolism[J]. Blood, 2020, 135(5): 317-325.
[2] 曹国磊, 吐尔逊江, 唐乐, 等.新疆地区维吾尔族与汉族恶性肿瘤并发静脉血栓栓塞患者399 例临床分析[J].重庆医学, 2018, 47(6):789-791.
CAO Guolei, TURXUN Jiang, TANG Le, et al. Clinical analysis of 399 cases of Uygur and Han malignant tumors complicated by venous thromboembolism in Xinjiang[J]. Chongqing Medicine , 2018,47 (6) : 789-791.
[3] ANGHEL L, SASC?U R, RADU R, et al. From classical laboratory parameters to novel biomarkers for the diagnosis of venous thrombosis[J]. International Journal of Molecular Sciences, 2020, 21(6): 1920.
[4] DE TOLEDO A O N, DO COUTO A M D, MADEIRA M F M, et al. Cytokines and chemokines associated with Treg/Th17 response in chronic inflammatory periapical disease[J]. Brazilian Oral Research, 2019,33(10): e093.
[5] 顾娜, 刘洪斌.Th17/Treg 免疫失衡在肺部疾病中的研究进展[J]. 天津药学, 2019, 31(2):58-62.
GU Na, LIU Hongbin. Research progress of Th17/Treg immune imbalance in pulmonary disease [J]. Tianjin Pharmacy, 2019,31 (2) : 58-62.
[6] 杨文娟, 夏仲尼, 王晓栋, 等.免疫细胞和细胞因子在深静脉血栓形成中的研究进展[J].中华全科医学,2019, 17(11):1898-1901.
YANG Wenjuan, XIA Zhongni, WANG Xiaodong, et al. Advance of research on immune cells and cytokines in deep vein thrombosis [J]. Chinese Journal of General Practice,2019,17(11):1898-1901.
[7] 季顺东.血栓形成机制及抗凝药物的药理特点[J].中国计划生育和妇产科, 2021, 13(3):25-28.
J I S h u n d o n g . Thrombosis mechanism and pharmacological characteristics of anticoagulants [J].Chinese Journal of Family Planning & Gynecotokology,201,13(3):25-28.
[8] KRUGER P C, EIKELBOOM J W, DOUKETIS J D,et al. Deep vein thrombosis: update on diagnosis and management[J]. The Medical Journal of Australia,2019, 210(11): 516-524.
[9] LOOMBA R S, AGGARWAL G, VILLARREAL E G,et al. Factors associated with deep venous thrombosis in patients infected with coronavirus disease 2019: A meta-analysis[J]. Blood Coagulation & Fibrinolysis,2021, 32(1): 23-28.
[10] AUDU C O, GORDON A E, OBI A T, et al.Inflammatory biomarkers in deep venous thrombosis organization, resolution, and post-thrombotic syndrome[J]. Journal of Vascular Surgery Venous and Lymphatic Disorders, 2020, 8(2): 299-305.
[11] MOAAZ M, YOUSSRY S, ELFATATRY A, et al. Th17/Treg cells imbalance and their related cytokines (IL-17,IL-10 and TGF-β) in children with autism spectrum disorder [J]. J Neuroimmunol,2019 ,337:577071.
[12] 高硕, 徐学静, 王森, 等. 免疫性血小板减少患者外周血Treg 及Th1,Th2 细胞检测及其临床意义[J]. 现代检验医学杂志, 2018, 33(1):112-114.
GAO Shuo, XU Xuejing, WANG Sen, et al. Detection and clinical significance of Treg and Th1,Th2 cells in peripheral blood of patients with immune thrombocytopenia [J]. Journal of Modern Laboratory Medicine,2018,33(1):112-114.
[13] 王彬, 刘明, 张玉冬, 等.消栓通脉颗粒调节Treg/Th17 亚群平衡治疗下肢深静脉血栓形成研究[J].山东中医药大学学报, 2013, 37(3):203-205,207.
WANG Bin, LIU Ming, ZHANG Yudong, et al. Effect of Xiaoshuan Tongmai Granule on Treg/Th17 subgroup balance in treatment of lower extremity deep vein thrombosis [J]. Journal of Shandong University of Traditional Chinese Medicine,2013,37(3):203-205,207.
[14] 孙涛, 李霞, 王彬.中药单体绿原酸对深静脉血栓形成大鼠Th17/Treg 亚群失衡的影响[J]. 山东医药,2015, 55(8):4-6.
SUN Tao, LI Xia, WANG Bin. Effect of chlorogenic acid on Th17 / Treg shift in deep vein thrombasis rats [J].Shandong Medical Journal,2015,55(8):4-6.
[15] DING Peiwu, ZHANG Shaoshao, YU Miao, et al. IL-17A promotes the formation of deep vein thrombosis in a mouse model[J]. International Immunopharmacology,2018, 57: 132-138.
[16] NOSAKA M, ISHIDA Y, KIMURA A, et al. Crucial involvement of IL-6 in thrombus resolution in mice via macrophage recruitment and the induction of proteolytic enzymes[J]. Frontiers in Immunology, 2019,10: 3150.
[17] 赵琳, 黄安斌. 细胞因子在静脉血栓栓塞形成中的研究进展[J]. 临床医学研究与实践, 2021, 6(1): 196-198.
ZHAO Lin, HUANG Anbin. Research progress of cytokines in venous thromboembolism [J]. Clinical Research and Practice, 2021,6(1):196-198.
[18] MUHAMMAD Y F, WONG K K, MOHD R N.
Th1, Th2, and Th17 cytokines in systemic lupus erythematosus[J]. Autoimmunity, 2020, 53(1): 8-20.
[19] KNOCHELMANN H M, DWYER C J, SMITH A S, et al. IL-6 fuels durable memory for Th17 cell-mediated responses to tumors[J]. Cancer Research, 2020, 80(18):3920-3932.
[20] BERTIN F R, RYS R N, MATHIEU C, et al.Natural killer cells induce neutrophil extracellular trap formation in venous thrombosis[J]. Journal of Thrombosis and Haemostasis: 2019, 17(2): 403-414.
[21] 吕慧珍, 李侃, 艾玎.整合素的作用及其应用: 心血管疾病治疗新靶点[J]. 中国动脉硬化杂志, 2021,29(2): 98-105.
L? Huizhen, LI Kan, AI Ding. Role and application of integrin: a new therapeutic target for cardiovascular disease [J]. Chinese Journal of Arteriosclerosis, 2021,29(2):98-105.
[22] XU X R, WANG Y M, ADILI R, et al. Apolipoprotein A-IV binds α I I b β 3 i n t e g r i n a n d i n h i b i t s thrombosis[J]. Nature Communications, 2018, 9(1):3608.
[23] QIAO Jianlin, WU Xiaoqing, LUO Qi, et al. NLRP3 regulates platelet in-tegrin ollb33 outside-in signaling,hemostasis and arterial thrombosis[J]. Haematologica,2018, 103(9):191700.